Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Pilot Trial	STARTED	Sulforaphane	10
Pilot Trial	STARTED	Placebo	0
Pilot Trial	COMPLETED	Sulforaphane	10
Pilot Trial	COMPLETED	Placebo	0
Pilot Trial	NOT COMPLETED	Sulforaphane	0
Pilot Trial	NOT COMPLETED	Placebo	0
Main Trial - Double Blind Phase	STARTED	Sulforaphane	25
Main Trial - Double Blind Phase	STARTED	Placebo	25
Main Trial - Double Blind Phase	COMPLETED	Sulforaphane	22
Main Trial - Double Blind Phase	COMPLETED	Placebo	23
Main Trial - Double Blind Phase	NOT COMPLETED	Sulforaphane	3
Main Trial - Double Blind Phase	NOT COMPLETED	Placebo	2
Main Trial - Open Label Phase	STARTED	Sulforaphane	45
Main Trial - Open Label Phase	STARTED	Placebo	0
Main Trial - Open Label Phase	COMPLETED	Sulforaphane	32
Main Trial - Open Label Phase	COMPLETED	Placebo	0
Main Trial - Open Label Phase	NOT COMPLETED	Sulforaphane	13
Main Trial - Open Label Phase	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02561481/flow